Skip to main content
Glama

Compare Entities

compare_entities
Read-onlyIdempotent

"Compare X and Y" / "X vs Y" / "X versus Y" / "which is bigger / better / larger / more profitable" / "rank these companies" / "head to head" — side-by-side comparison of 2–5 companies or drugs in ONE parallel call. ALWAYS PREFER over sequential single-pack lookups when comparing entities. type="company" pulls LATEST 10-K revenue + net income + cash + long-term debt from SEC EDGAR/XBRL (off-calendar fiscal years handled correctly — AAPL Sep, NVDA Jan, etc.). type="drug" pulls FAERS adverse-event counts, FDA approval counts, active trial counts. Results sorted by primary metric so "largest" / "most" / "biggest" reads off the top of the response. Returns paired data + pipeworx:// citation URIs per entity. Replaces 8–15 sequential lookups.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
typeYesEntity type: "company" or "drug".
valuesYesFor company: 2–5 tickers/CIKs (e.g., ["AAPL","MSFT"]). For drug: 2–5 names (e.g., ["ozempic","mounjaro"]).

TDQS

A4.8/5.0
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Annotations already indicate read-only, idempotent, non-destructive. Description adds valuable behavioral context: data sources (SEC EDGAR/XBRL for companies, FAERS for drugs), handling of off-calendar fiscal years, sorting by primary metric, and return of citation URIs. No contradiction with annotations.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness4/5

Is the description appropriately sized, front-loaded, and free of redundancy?

Well-structured with front-loaded examples and clear explanations. Some slight redundancy (e.g., 'side-by-side comparison' and 'compare entities'), but overall concise and easy to parse. Every sentence adds value.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness4/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

No output schema, but description mentions return of 'paired data' and citation URIs. Explains entity types and sources adequately. Could be more specific about the format of the paired data, but sufficient for an agent to understand the output.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters5/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Input schema has 100% coverage with parameter descriptions, but the description adds crucial semantics: for 'type' it explains the data sources and for 'values' it specifies tickers/CIKs for companies and drug names, with concrete examples. This significantly aids correct invocation.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description clearly states the tool performs side-by-side comparisons of 2-5 companies or drugs, with specific example triggers like 'Compare X and Y' and 'X vs Y'. It distinguishes itself from sequential single-entity lookups, directly addressing sibling tools like 'entity_profile'.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines5/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

Explicit guidance on when to use: for comparison queries, ranking, head-to-head. Includes a strong recommendation to prefer over sequential lookups. Provides examples of user intents that trigger this tool, and specifies constraints (2-5 entities).

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

Try in Browser

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

A4/5.0
Disambiguation3/5

Most tools have distinct purposes, but several clusters overlap: ask_pipeworx_beta is currently identical to ask_pipeworx, polymarket_arbitrage and polymarket_edges both surface arbitrage opportunities, and validate_claim overlaps with ask_pipeworx_grounded. Descriptions mitigate some confusion, but selection errors are still likely.

Naming Consistency4/5

Names are overwhelmingly lowercase snake_case and descriptive, such as nist_control_family, polymarket_fill_risk, and list_subscriptions. Minor deviations exist with single-word memory verbs like remember/recall/forget and the ask_pipeworx_* variants, but the overall pattern is predictable and readable.

Tool Count2/5

34 tools is well above the comfortable range and includes many tools unrelated to the server's NIST Standards name, such as Polymarket betting, npm dependency scanning, AI visibility checks, and llms.txt generation. The set feels like a broad general-purpose data platform rather than a scoped NIST reference server.

Completeness3/5

For the NIST domain, the three control tools provide id lookup, family listing, and keyword search, but there is no catalog overview or family enumeration, and no comparison, revision, or export capability. The other 31 tools do not fill those gaps, so the NIST surface is functional but not fully complete for compliance workflows.